Back to mobile site

Avanir Pharmaceuticals (AVNR) volatility elevated into PDUFA

October 18, 2010 8:08 AM EDT Send to a Friend
Avanir Pharmaceuticals (Nasdaq: AVNR) is developing Zenvia for PBA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login